Bing

SEARCH HISTORY

Healthcare has been far and away the best sector of 2015 so far — and biotech stocks are no exception ... Biopharmaceuticals (KERX) as well. At the Feb. 18 close, Profit Scanner spotted a Head and Shoulders Bottom on KERX stock’s chart.
NASDAQ · 2/20/2015
Keryx Biopharmaceuticals Inc. (KERX - Analyst Report) was a big mover last session ... Yesterday’s rally reverses the recent downtrend for the company, as the stock is now down over 14% in the past one-month time frame. Over the last 7 days, the …
ZACKS · 5/12/2015
Small cap Keryx Biopharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products geared towards addressing unmet needs and providing unique and meaningful advantages to …
Smallcap Network · ByJohn Udovich · 12/2/2014
More from Bing News
Oppenheimer's research report indicates that KERX's Zenerex is valued alone at $3.10 per share which supports KERX's stock price, even without Perifosine. Thus, Perifosine's results offer significant upside with limited downside and KERX's stock could ...
Seeking Alpha · ByJeremy Richards · 3/2/2012
Even so, short-sellers have been piling into the stock ahead of the drug's Prescription Drug User Fee Act goal date of Sept. 7, 2014. KERX data by YCharts. With short-sellers now holding close to 23% of the float, it's important to consider four reasons ...
The Motley Fool · 6/7/2014
May 14, 2013 (ACCESSWIRE-TNW via COMTEX) -- New York, NY -- (ACCESSWIRE) -- 05/14/2013 -- Growing Stock Report initiates a Biotech Watch List adding Keryx Biopharmaceuticals Inc. KERX, +0.70% Ariad Pharmaceuticals Inc. ARIA, +0.34% …
Market Watch · 5/15/2013
Keryx Biopharmaceuticals (NASDAQ:KERX) has potential upside of 116.2% based on a current price of $9.99 and analysts' consensus price target of $21.60. The stock should run into initial resistance at its 50-day moving average (MA) of $10.80 and …
Financial News Network Online · ByPeter Chu · 6/17/2015
Keryx Biopharmaceuticals
Options can provide significant leverage if the stock moves in the right direction but aslo end up worthless if it doesn't. Shares of Keryx Biopharmaceuticals rose $0.09 (0.72%) to $12.51 in today's trading session. The price of KERX ranged between $12.28 ...
AVAFIN · 4/13/2015
Of all the stocks that fall into this category, there is one stock that fits the bill at the current time and that company is Keryx Biopharmaceuticals. Keryx trades under the ticker symbol KERX and trades on the NASDAQ. The company is headed in New York.
Examiner · 4/28/2011
Netflix (NASDAQ: NFLX) 15.2% HIGHER; reported Q4 EPS of $0.72, $0.27 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion. Domestic steaming subscribers rose 1.9 …
StreetInsider · 1/20/2015